In this segment of the Pharmaceutical Executive Video Interviews, Chairman of the FDA Regulatory Affairs Division, Jim Sheehan of Lowenstein Sandler, shares his advice for investors and financiers considering entering the weight loss drug market.
Advice for investors entering the weight loss market
Leave a comment
